Tamiflu Side Effects


Tamiflu DeathsTamiflu Side Effects

Tamiflu Stevens-Johnson Syndrome reaction

Tamiflu Reaction


Swineflu drug Tamiflu is being cited as cause of deaths in Britain

We are in the process of putting together some big research which will be out in December......

The Government says Tamiflu was not directly responsible. But experts have serious concerns and promise big new research.

Swine flu drug Tamiflu has been blamed for the deaths of 13 UK patients, including two children, we can reveal.

The Government regulatory body says it has investigated the deaths and said Tamiflu was not directly responsible......

Two of the 13 cases were patients under the age of 18, while eight were aged between 18 and 64, two over 65 and one was listed unknown.......

Dr Carl Heneghan, one of a group of international health specialists looking at the safety and effectiveness of the drug, said: There are serious concerns. In Japan it has a black box warning for adolescents....

Our probe, which looked at all the suspected adverse reactions reported to the Medicines and Healthcare products Regulatory Agency (MHRA) since the 2009 swine flu pandemic, found that among 1,140 reports, a total of 2,084 reactions were recorded, with 13 deaths.

Studies in Japan say there are links between the drug and suicides, with one research paper saying five deaths in the country three during sleep and two following accidents caused by abnormal behaviour were linked to Tamiflu......

Dr Heneghan, a director of the Centre for Evidence-Based Medicine at Oxford University, said for most otherwise healthy patients Tamiflu was no more beneficial than paracetamol.

He said: It is not a cure and the current evidence still does not say it is actually going to benefit you.

The MHRA, which has ruled the medicine safe, said the balance of risks and benefits for Tamiflu remains positive.

It said reports surrounding the 13 deaths had been fully evaluated and there was no indication that Tamiflu was directly responsible, instead blaming patients underlying ill-health.

Tamiflu maker Roche said: The well-being of patients and the appropriate and effective use of our medications is an unwavering priority.

Tamiflu has been used to treat and prevent influenza in over 83million people, including nearly 17million children from over 80 countries and studies show it is well tolerated in the overwhelming majority.